← Back to Vaccine Database

MF59 adjuvanted SARS-CoV-2 Sclamp vaccine

Protein based vaccine · VDDBV0479

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04495933 Phase 1COVID-19